+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
DNA Plasmid Manufacturing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User and Geography- Product Image
DNA Plasmid Manufacturing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User and Geography- Product Image
New

DNA Plasmid Manufacturing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User and Geography

  • PDF Icon

    Report

  • 222 Pages
  • June 2025
  • Region: Global
  • The Insight Partners
  • ID: 6102999
Description Jump to:
The DNA plasmid Manufacturing Market is expected to reach US$ 2.64 billion by 2031 from US$ 686.38 Mn in 2024; the market is estimated to grow at a CAGR of 21.4% during 2025-2031. Major factors driving the market growth include increasing plasmid developments for gene therapy and growing research on DNA plasmid vaccine development. However, high manufacturing costs among the market deterrents.

The rise in the prevalence of genetic diseases, orphan diseases, and other cancers has accelerated the advancement of gene therapy technologies, which are based largely on plasmid DNA as the fundamental element. Plasmid DNA helps introduce genetic material into patients' cells. It acts as a non-viral vector to deliver therapeutic genes that can fix or replace faulty genes. Unlike viral vectors, plasmids are safer, easier to produce, and cheaper, making them popular in gene therapy.

As gene therapies transition from preclinical development to clinical trials and commercial launch, the demand for substantial quantities of high-purity, GMP-grade plasmid DNA has escalated significantly. In March 2023, Charles River Laboratories International, Inc. announced the launch of its off-the-shelf pHelper (Helper Plasmid) offering, which is designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing.
Growing partnerships between companies to meet the quality and regulatory demands of gene therapy pipelines. In 2022, Myrtelle and Forge Biologics announced a viral vector and plasmid DNA cGMP manufacturing partnership. Forge will provide research-grade and GMP-Pathway plasmid manufacturing services as well as cGMP adeno-associated viral (AAV) process development and scale-up manufacturing services for Myrtelle’s program, Myr-201 (novel gene therapy for monogenic hearing loss).

Governments and regulatory agencies are also helping to drive this trend with expedited approvals for gene therapy products and national biotech infrastructure investment. VGXI, Inc. recently completed a successful FDA inspection at its GMP facility in Conroe, Texas. This inspection led to the approval of a client’s Biologics License Application (BLA). VGXI’s achievement reinforces its credibility as a plasmid DNA manufacturing leader as well as underscores its importance in enabling commercial-stage gene therapies, DNA vaccines, and RNA-based medicines.

The DNA plasmid market is transforming from a specialized research supply chain to an essential backbone of contemporary therapeutic development. Therefore, the increasing development of plasmid for gene therapy drives the DNA plasmid manufacturing market.

The comparative company analysis evaluates and categorizes the DNA plasmid Manufacturing Market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global DNA plasmid Manufacturing Market. The key market players are WuXi Biologics Inc, Charles River Laboratories International Inc, Catalent Inc, Thermo Fisher Scientific Inc., AGC Biologics AS, Takara Bio Inc, SK pharmteco Inc, Sartorius, Creative Biogene, GenScript Biotech Corporation

The DNA plasmid Manufacturing Market, based on product type, is divided into GMP Grade and R&D grade. The GMP Grade segment held the largest share of the DNA plasmid Manufacturing Market in 2024, and it is expected to register the highest CAGR during 2024-2031. Based on Application, the DNA plasmid Manufacturing Market is segmented into Cell and Gene Therapy, DNA Vaccines, Immunotherapy, and Others. In 2024, the cell and gene therapy segment held the largest share of the market. Based on end user, the DNA plasmid Manufacturing Market is segmented into Pharmaceutical and Biotechnology Companies, CROs and CDMOs and Others. In 2024, the Pharmaceutical and Biotechnology Companies segment held the largest share of the market.
Various organic and inorganic strategies are adopted by companies operating in the DNA plasmid Manufacturing Market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the DNA plasmid Manufacturing Market are listed below.

In March 2025, WuXi Biologics Launched EffiX Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production. EffiX is designed to meet the industry’s demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for developing and manufacturing non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the globe. EffiX delivers high-yield production across multiple modalities, achieving titers of over 15 g/L for non-mAb recombinant proteins and over 1 g/L for plasmid DNA.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the DNA Plasmid Manufacturing Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global DNAPlasmid Manufacturing Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. DNA Plasmid Manufacturing Market Landscape
4.1 PEST Analysis
5. DNA Plasmid Manufacturing Market - Key Market Dynamics
5.1 DNA Plasmid Manufacturing Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Plasmid Developments for Gene Therapy
5.2.2 Growing Research on DNA Plasmid Vaccine Development
5.3 Market Restraints
5.3.1 High Manufacturing Costs
5.4 Market Opportunities
5.4.1 Expansion of Contract Development and Manufacturing Organizations (CDMOs)
5.5 Future Trends
5.5.1 Integration of Digital Technologies in Plasmid DNA Manufacturing
5.6 Impact of Drivers and Restraints:
6. DNA Plasmid Manufacturing Market - Global Market Analysis
6.1 DNA Plasmid Manufacturing Market Revenue (US$ Million), 2021-2031
6.2 DNA Plasmid Manufacturing Market Forecast Analysis
7. DNA Plasmid Manufacturing Market Analysis - by Product Type
7.1 GMP Grade
7.1.1 Overview
7.1.2 GMP Grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
7.2 R&D grade
7.2.1 Overview
7.2.2 R&D grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
8. DNA Plasmid Manufacturing Market Analysis - by Application
8.1 Cell and Gene Therapy
8.1.1 Overview
8.1.2 Cell and Gene Therapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
8.2 DNA Vaccines
8.2.1 Overview
8.2.2 DNA Vaccines: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Immunotherapy
8.3.1 Overview
8.3.2 Immunotherapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
9. DNA Plasmid Manufacturing Market Analysis - by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
9.2 CROs and CDMOs
9.2.1 Overview
9.2.2 CROs and CDMOs: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10. DNA Plasmid Manufacturing Market - Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America DNA Plasmid Manufacturing Market Overview
10.2.2 North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
10.2.3 North America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.2.3.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
10.2.4 North America: DNA Plasmid Manufacturing Market Breakdown, by Application
10.2.4.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
10.2.5 North America: DNA Plasmid Manufacturing Market Breakdown, by End User
10.2.5.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
10.2.6 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
10.2.6.1 North America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
10.2.6.2 United States: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2.6.2.1 United States: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.2.6.2.2 United States: DNA Plasmid Manufacturing Market Breakdown, by Application
10.2.6.2.3 United States: DNA Plasmid Manufacturing Market Breakdown, by End User
10.2.6.3 Canada: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2.6.3.1 Canada: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.2.6.3.2 Canada: DNA Plasmid Manufacturing Market Breakdown, by Application
10.2.6.3.3 Canada: DNA Plasmid Manufacturing Market Breakdown, by End User
10.2.6.4 Mexico: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2.6.4.1 Mexico: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.2.6.4.2 Mexico: DNA Plasmid Manufacturing Market Breakdown, by Application
10.2.6.4.3 Mexico: DNA Plasmid Manufacturing Market Breakdown, by End User
10.3 Europe
10.3.1 Europe DNA Plasmid Manufacturing Market Overview
10.3.2 Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
10.3.3 Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.3.3.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
10.3.4 Europe: DNA Plasmid Manufacturing Market Breakdown, by Application
10.3.4.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
10.3.5 Europe: DNA Plasmid Manufacturing Market Breakdown, by End User
10.3.5.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
10.3.6 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
10.3.6.1 Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
10.3.6.2 Germany: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.2.1 Germany: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.3.6.2.2 Germany: DNA Plasmid Manufacturing Market Breakdown, by Application
10.3.6.2.3 Germany: DNA Plasmid Manufacturing Market Breakdown, by End User
10.3.6.3 United Kingdom: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.3.1 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.3.6.3.2 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by Application
10.3.6.3.3 United Kingdom: DNA Plasmid Manufacturing Market Breakdown, by End User
10.3.6.4 France: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.4.1 France: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.3.6.4.2 France: DNA Plasmid Manufacturing Market Breakdown, by Application
10.3.6.4.3 France: DNA Plasmid Manufacturing Market Breakdown, by End User
10.3.6.5 Italy: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.5.1 Italy: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.3.6.5.2 Italy: DNA Plasmid Manufacturing Market Breakdown, by Application
10.3.6.5.3 Italy: DNA Plasmid Manufacturing Market Breakdown, by End User
10.3.6.6 Spain: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.6.1 Spain: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.3.6.6.2 Spain: DNA Plasmid Manufacturing Market Breakdown, by Application
10.3.6.6.3 Spain: DNA Plasmid Manufacturing Market Breakdown, by End User
10.3.6.7 Rest of Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.7.1 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.3.6.7.2 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by Application
10.3.6.7.3 Rest of Europe: DNA Plasmid Manufacturing Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific DNA Plasmid Manufacturing Market Overview
10.4.2 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
10.4.3 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.4.3.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
10.4.4 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Application
10.4.4.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
10.4.5 Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by End User
10.4.5.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
10.4.6 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
10.4.6.1 Asia Pacific: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
10.4.6.2 China: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.6.2.1 China: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.4.6.2.2 China: DNA Plasmid Manufacturing Market Breakdown, by Application
10.4.6.2.3 China: DNA Plasmid Manufacturing Market Breakdown, by End User
10.4.6.3 Japan: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.6.3.1 Japan: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.4.6.3.2 Japan: DNA Plasmid Manufacturing Market Breakdown, by Application
10.4.6.3.3 Japan: DNA Plasmid Manufacturing Market Breakdown, by End User
10.4.6.4 India: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.6.4.1 India: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.4.6.4.2 India: DNA Plasmid Manufacturing Market Breakdown, by Application
10.4.6.4.3 India: DNA Plasmid Manufacturing Market Breakdown, by End User
10.4.6.5 Australia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.6.5.1 Australia: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.4.6.5.2 Australia: DNA Plasmid Manufacturing Market Breakdown, by Application
10.4.6.5.3 Australia: DNA Plasmid Manufacturing Market Breakdown, by End User
10.4.6.6 South Korea: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.6.6.1 South Korea: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.4.6.6.2 South Korea: DNA Plasmid Manufacturing Market Breakdown, by Application
10.4.6.6.3 South Korea: DNA Plasmid Manufacturing Market Breakdown, by End User
10.4.6.7 Rest of APAC: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.6.7.1 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.4.6.7.2 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by Application
10.4.6.7.3 Rest of APAC: DNA Plasmid Manufacturing Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa DNA Plasmid Manufacturing Market Overview
10.5.2 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
10.5.3 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.5.3.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
10.5.4 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
10.5.4.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
10.5.5 Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
10.5.5.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
10.5.6 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
10.5.6.1 Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
10.5.6.2 Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5.6.2.1 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.5.6.2.2 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by Application
10.5.6.2.3 Saudi Arabia: DNA Plasmid Manufacturing Market Breakdown, by End User
10.5.6.3 South Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5.6.3.1 South Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.5.6.3.2 South Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
10.5.6.3.3 South Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
10.5.6.4 United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5.6.4.1 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.5.6.4.2 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by Application
10.5.6.4.3 United Arab Emirates: DNA Plasmid Manufacturing Market Breakdown, by End User
10.5.6.5 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5.6.5.1 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.5.6.5.2 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application
10.5.6.5.3 Rest of Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America DNA Plasmid Manufacturing Market Overview
10.6.2 South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
10.6.3 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.6.3.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Product Type
10.6.4 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application
10.6.4.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Application
10.6.5 South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User
10.6.5.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by End User
10.6.6 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
10.6.6.1 South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast Analysis - by Country
10.6.6.2 Brazil: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.6.6.2.1 Brazil: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.6.6.2.2 Brazil: DNA Plasmid Manufacturing Market Breakdown, by Application
10.6.6.2.3 Brazil: DNA Plasmid Manufacturing Market Breakdown, by End User
10.6.6.3 Argentina: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.6.6.3.1 Argentina: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.6.6.3.2 Argentina: DNA Plasmid Manufacturing Market Breakdown, by Application
10.6.6.3.3 Argentina: DNA Plasmid Manufacturing Market Breakdown, by End User
10.6.6.4 Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.6.6.4.1 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type
10.6.6.4.2 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application
10.6.6.4.3 Rest of South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis by Key Players
11.2 Company Market Share Analysis, 2024
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Sartorius AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 WuXi Biologics Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Charles River Laboratories International Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Catalent Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 AGC Biologics AS
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Takara Bio Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.8 Creative Biogene
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 SK Pharmteco Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 GenScript Biotech Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
List of Tables
Table 1. DNA Plasmid Manufacturing Market Segmentation
Table 2. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million)
Table 3. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million)
Table 4. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 5. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 6. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 7. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 8. DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 9. DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 10. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 11. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 12. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 13. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 14. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 15. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 16. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 17. North America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 18. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 19. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 20. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 21. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 22. United States: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 23. United States: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 24. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 25. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 26. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 27. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 28. Canada: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 29. Canada: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 30. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 31. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 32. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 33. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 34. Mexico: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 35. Mexico: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 36. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 37. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 38. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 39. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 40. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 41. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 42. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 43. Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 44. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 45. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 46. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 47. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 48. Germany: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 49. Germany: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 50. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 51. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 52. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 53. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 54. United Kingdom: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 55. United Kingdom: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 56. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 57. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 58. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 59. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 60. France: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 61. France: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 62. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 63. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 64. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 65. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 66. Italy: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 67. Italy: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 68. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 69. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 70. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 71. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 72. Spain: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 73. Spain: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 74. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 75. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 76. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 77. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 78. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 79. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 80. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 81. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 82. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 83. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 84. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 85. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 86. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 87. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 88. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 89. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 90. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 91. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 92. China: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 93. China: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 94. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 95. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 96. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 97. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 98. Japan: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 99. Japan: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 100. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 101. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 102. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 103. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 104. India: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 105. India: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 106. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 107. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 108. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 109. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 110. Australia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 111. Australia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 112. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 113. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 114. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 115. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 116. South Korea: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 117. South Korea: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 118. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 119. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 120. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 121. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 122. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 123. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 124. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 125. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 126. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 127. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 128. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 129. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 130. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 131. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 132. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 133. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 134. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 135. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 136. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 137. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 138. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 139. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 140. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 141. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 142. South Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 143. South Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 144. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 145. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 146. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 147. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 148. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 149. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 150. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 151. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 152. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 153. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 154. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 155. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 156. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 157. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 158. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 159. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 160. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 161. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 162. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 163. South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 164. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 165. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 166. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 167. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 168. Brazil: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 169. Brazil: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 170. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 171. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 172. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 173. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 174. Argentina: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 175. Argentina: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 176. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 177. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 178. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 179. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 180. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 181. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 182. Heat Map Analysis by Key Players
Table 183. Recent Organic Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
Table 184. Recent Inorganic Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
Table 185. Glossary of Terms, Infectious Disease Diagnostics Market
List of Figures
Figure 1. DNA Plasmid Manufacturing Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. DNA Plasmid Manufacturing Market Revenue (US$ Million), 2021-2031
Figure 5. DNA Plasmid Manufacturing Market Share (%) - by Product Type (2024 and 2031)
Figure 6. GMP Grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. R&D grade: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. DNA Plasmid Manufacturing Market Share (%) - by Application (2024 and 2031)
Figure 9. Cell and Gene Therapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. DNA Vaccines: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Immunotherapy: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. DNA Plasmid Manufacturing Market Share (%) - by End User (2024 and 2031)
Figure 14. Pharmaceutical and Biotechnology Companies: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. CROs and CDMOs: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: DNA Plasmid Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. DNA Plasmid Manufacturing Market Breakdown by Region, 2024 and 2031 (%)
Figure 18. North America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
Figure 19. North America: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
Figure 20. North America: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 21. North America: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 22. North America: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 23. United States: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 24. Canada: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 25. Mexico: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 26. Europe: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
Figure 27. Europe: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
Figure 28. Europe: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 29. Europe: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 30. Europe: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 31. Germany: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 32. United Kingdom: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 33. France: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 34. Italy: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 35. Spain: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 36. Rest of Europe: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 37. Asia Pacific: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
Figure 38. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
Figure 39. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 40. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 41. Asia Pacific: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 42. China: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 43. Japan: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 44. India: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 45. Australia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 46. South Korea: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 47. Rest of APAC: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 48. Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
Figure 49. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
Figure 50. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 51. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 52. Middle East and Africa: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 53. Saudi Arabia: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 54. South Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 55. United Arab Emirates: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 56. Rest of Middle East and Africa: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 57. South and Central America: DNA Plasmid Manufacturing Market - Revenue, 2021-2031 (US$ Million)
Figure 58. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Product Type (2024 and 2031)
Figure 59. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 60. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 61. South and Central America: DNA Plasmid Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 62. Brazil: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 63. Argentina: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 64. Rest of South and Central America: DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 65. Company Market Share Analysis, 2024
Figure 66. Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market

Companies Mentioned

Some of the leading companies in the DNA Plasmid Manufacturing Market include:
  • WuXi Biologics Inc
  • Charles River Laboratories International Inc
  • Catalent Inc
  • Thermo Fisher Scientific Inc.
  • AGC Biologics AS
  • Takara Bio Inc
  • SK pharmteco Inc
  • Sartorius
  • Creative Biogene
  • GenScript Biotech Corporation

Table Information

Report AttributeDetails
No. of Pages222
PublishedJune 2025
Forecast Period2024 - 2031
Estimated Market Value ( USD ) in 2024 $ 686.38 Million
Forecasted Market Value ( USD ) by 2031 $ 2640 Million
Compound Annual Growth Rate21.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Plasmid DNA Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031 - Product Image

Plasmid DNA Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031

  • Report
  • 119 Pages
  • Global
From
Viral Vector and Plasmid DNA Manufacturing Market - Global Forecast to 2028 - Product Image

Viral Vector and Plasmid DNA Manufacturing Market - Global Forecast to 2028

  • Report
  • 317 Pages
  • Global
From
Plasmid DNA Contract Manufacturing - Global Strategic Business Report - Product Image

Plasmid DNA Contract Manufacturing - Global Strategic Business Report

  • Report
  • 170 Pages
  • Global
From
Plasmid DNA Manufacturing - Global Strategic Business Report - Product Image

Plasmid DNA Manufacturing - Global Strategic Business Report

  • Report
  • 475 Pages
  • Global
From
Viral Vectors & Plasmid DNA Manufacturing Market Report 2025-2035 - Product Image

Viral Vectors & Plasmid DNA Manufacturing Market Report 2025-2035

  • Report
  • 483 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.